Loading interface...

Rantac 150 MG Injection

Manufactured byJb Chemicals And Pharmaceuticals Ltd.
ContainsRanitidine
Description

Rantac 150 MG Injection is used to reduce the amount of acid produced in the stomach. It is used to treat stomach ulcers, gastroesophageal reflux disease (GERD), and other acidity related disorders in hospitalized patients or who are unable to take oral forms of ranitidine.

Side effects

Major & minor side effects for Rantac 150 MG Injection

  • Headache
  • Dizziness
  • Pain at the injection site
  • Diarrhea
  • Skin rash
  • Mental confusion
  • Muscle pain
  • Difficulty in breathing
  • Gynecomastia (Growth of breast in males)

Uses of Rantac 150 MG Injection

What is it prescribed for?

  • Gastroesophagal Reflux Disease
  • Zollinger-Ellison Syndrome
  • Erosive Esophagitis
  • Hypersecretory Condition
  • Duodenal Ulcer
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The effect of this medicine can be observed after one hour of administration.
  • How long do the effects of this medicine last?
    The effect of this medicine lasts for an average duration of 4-5 hours.
  • Is it safe to consume alcohol while taking this medicine?
    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Is this a habit forming medicine?
    No habit-forming tendencies were reported.
  • Can this medicine be taken during pregnancy?
    This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before receiving this medicine.
  • Can this medicine be taken while breast-feeding?
    This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before receiving this medicine.

Allergy

This medicine is not recommended for use in patients with a known allergy to ranitidine or any other inactive ingredients present along with the formulation.

Porphyria

This medicine is not recommended for use in patients with porphyria, a disorder that results from a buildup of porphyrin in the body.
Warnings for special population

Pregnancy

This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before receiving this medicine.

Breast-feeding

This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before receiving this medicine.
General warnings

Pneumonia

The use of this medicine may increase the risk of developing pneumonia. Symptoms like chest pain, fever. difficulty in breathing and the presence of green or yellow mucus with a cough is to be reported to the doctor on priority. Appropriate corrective measures, dose adjustments, or replacement with a suitable alternative may be required in such cases based on the clinical condition.

Chronic heartburn

If you have chronic heartburn (more than 3 months) or your heartburn continues or worsens, consult your doctor immediately since this may be a sign of a more serious condition. Appropriate dose adjustments or replacement with a suitable alternative may be required in such cases based on the clinical condition.

Gastrointestinal bleeding

This medicine is not recommended for use in patients with severe gastrointestinal bleeding since it may worsen the patient's condition. Replacement with a suitable alternative should be done under your doctor's supervision.

Missed Dose

Since this medicine is usually administered by a qualified healthcare professional in the clinical/hospital setting, the likelihood of a missed dose is very low.

Overdose

Since this medicine is administered in the hospital setting by a qualified healthcare professional, the likelihood of an overdose is very less. However, emergency medical treatment will be initiated by the doctor if an overdose is suspected.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine

Ketoconazole

Loperamide

Metformin

Atazanavir

Dasatinib

Pazopanib

Disease interactions

Liver Disease

This medicine should be used with caution in patients suffering from liver impairment due to the increased risk of severe adverse effects. Close monitoring of liver function tests is necessary while receiving this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

Kidney disease

This medicine should be used with caution in patients suffering from kidney impairment due to the increased risk of severe adverse effects. Close monitoring of kidney function tests is necessary while receiving this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.
Food interactions
Information not available.
Lab interactions
Information not available.
This medicine is usually administered in the clinical/hospital setting under the supervision of a qualified healthcare professional. Follow all the instructions given by your doctor. Inform the doctor if you have a known allergy to this medicine. Report all your current medicines as well as your medical conditions to the doctor before receiving this medicine.
Miscelleneous

Usage does not depend on food timings

To be taken as instructed by doctor

Does not cause sleepiness

How it works
This medicine works by reducing the amount of acid produced in the stomach.
Legal Status

Approved

Unknown

Approved

Approved

Classification

Category

H2 antagonists

Schedule

Schedule H

Ranitidine Injection: MedlinePlus Drug Information [Internet]. Medlineplus.gov. 2020 [cited 2 March 2020]. Available from:

https://medlineplus.gov/druginfo/meds/a601164.html

[Internet]. Medicines.org.uk. 2020 [cited 2 March 2020]. Available from:

https://www.medicines.org.uk/emc/files/pil.4453.pdf

Ranitidine Injection, USP [Internet]. Dailymed.nlm.nih.gov. 2020 [cited 2 March 2020]. Available from:

https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=9268c1df-bcf3-4899-896d-044492802a33&type=display

[Internet]. Accessdata.fda.gov. 2020 [cited 2 March 2020]. Available from:

https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/019090s053,019593s042lbl.pdf
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 20 May 2020

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.